Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM154EB)

Drug Name
Lypressin Drug Info
Synonyms Lysine-vasopressin; Lysine-8-vasopressin
Indication
Disease Entry ICD 11 Status REF
Amnesia MB21.1 Approved [1]
Cross-matching ID
PubChem CID
644076
ChEBI ID
CHEBI:94802
CAS Number
CAS 50-57-7
TTD Drug ID
DM154EB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Vasopressin V1 receptor (V1R)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [3]
Mozavaptan DMZ905C Hyponatraemia 5C72 Approved [4]
OPC-21268 DM7OVMH Cardiac disease BA00-BE2Z Discontinued in Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Vasopressin V1 receptor (V1R) TTPFZJ1 NOUNIPROTAC Modulator [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2172).
2 Human pain thresholds after the application of lypressin, a vasopressin analogue. Pharmacol Toxicol. 1987 Jul;61(1):16-9.
3 Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol. 1996 May;7(5):805-10.
4 Vasopressin (ADH). Nippon Rinsho. 1992 Dec;50(12):2893-900.